Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| AMP-Activated Protein Kinases | 4 | 2024 | 162 | 1.600 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2019 | 722 | 1.580 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2020 | 12 | 0.700 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4396 | 0.630 |
Why?
|
| Metformin | 1 | 2020 | 152 | 0.610 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2019 | 152 | 0.600 |
Why?
|
| Embryonic Development | 4 | 2019 | 214 | 0.500 |
Why?
|
| Embryo, Mammalian | 5 | 2019 | 460 | 0.480 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 350 | 0.460 |
Why?
|
| CHARGE Syndrome | 1 | 2014 | 8 | 0.460 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2523 | 0.370 |
Why?
|
| Mice | 11 | 2024 | 17644 | 0.330 |
Why?
|
| Signal Transduction | 2 | 2020 | 4534 | 0.310 |
Why?
|
| Phosphorylation | 2 | 2024 | 1631 | 0.300 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 1660 | 0.300 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 958 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 1893 | 0.280 |
Why?
|
| Phenotype | 3 | 2019 | 4258 | 0.270 |
Why?
|
| Animals | 11 | 2024 | 34234 | 0.250 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 429 | 0.240 |
Why?
|
| Mice, Knockout | 5 | 2019 | 3742 | 0.210 |
Why?
|
| Disease | 1 | 2024 | 129 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 1006 | 0.210 |
Why?
|
| Metabolism | 1 | 2020 | 42 | 0.170 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 123 | 0.170 |
Why?
|
| Graft vs Host Disease | 1 | 2024 | 540 | 0.160 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 166 | 0.160 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 18 | 0.160 |
Why?
|
| Neural Crest | 1 | 2019 | 55 | 0.160 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2019 | 55 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2304 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 158 | 0.140 |
Why?
|
| Tumor Protein p73 | 1 | 2017 | 22 | 0.140 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2016 | 17 | 0.130 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 444 | 0.130 |
Why?
|
| Pyrimidinones | 1 | 2016 | 49 | 0.130 |
Why?
|
| Thiophenes | 1 | 2016 | 70 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 2048 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2024 | 1196 | 0.120 |
Why?
|
| Gene Order | 1 | 2015 | 79 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2017 | 418 | 0.120 |
Why?
|
| Ear | 1 | 2014 | 25 | 0.120 |
Why?
|
| Genotype | 1 | 2020 | 2558 | 0.110 |
Why?
|
| Gene Targeting | 1 | 2015 | 177 | 0.110 |
Why?
|
| Mitochondria | 1 | 2019 | 684 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 177 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2016 | 343 | 0.110 |
Why?
|
| Lysosomes | 1 | 2016 | 236 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2016 | 347 | 0.110 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2014 | 8 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2014 | 115 | 0.110 |
Why?
|
| Hearing Loss, Conductive | 1 | 2014 | 13 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 357 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2014 | 64 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 579 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 79 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2015 | 339 | 0.110 |
Why?
|
| Inflammation | 1 | 2020 | 1440 | 0.100 |
Why?
|
| Limb Deformities, Congenital | 1 | 2014 | 106 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2017 | 799 | 0.100 |
Why?
|
| Craniofacial Abnormalities | 1 | 2014 | 240 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2014 | 231 | 0.100 |
Why?
|
| Heterozygote | 1 | 2014 | 671 | 0.100 |
Why?
|
| Apoptosis | 2 | 2019 | 1803 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 487 | 0.090 |
Why?
|
| Autophagy | 1 | 2015 | 393 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 618 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2014 | 789 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 1330 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1270 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2015 | 767 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2014 | 885 | 0.080 |
Why?
|
| Protein Binding | 1 | 2014 | 1752 | 0.080 |
Why?
|
| Alleles | 1 | 2014 | 1615 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1896 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3345 | 0.070 |
Why?
|
| Humans | 4 | 2024 | 124700 | 0.050 |
Why?
|
| Female | 4 | 2019 | 66570 | 0.050 |
Why?
|
| Intestines | 1 | 2024 | 576 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2019 | 19 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2024 | 909 | 0.040 |
Why?
|
| Yolk Sac | 1 | 2019 | 23 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2019 | 76 | 0.040 |
Why?
|
| Mesoderm | 1 | 2019 | 110 | 0.040 |
Why?
|
| Neural Tube | 1 | 2019 | 46 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2016 | 48 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 2016 | 90 | 0.030 |
Why?
|
| Endoderm | 1 | 2016 | 23 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1717 | 0.030 |
Why?
|
| Placenta | 1 | 2019 | 508 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2016 | 163 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 191 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 729 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 361 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 884 | 0.030 |
Why?
|
| Male | 2 | 2019 | 61314 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 4407 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 1958 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7171 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 5845 | 0.010 |
Why?
|